Qube Research & Technologies Ltd - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 41 filers reported holding LEAP THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$63,000
+50.0%
36,246
+62.1%
0.00%0.0%
Q1 2021$42,000
-83.5%
22,356
-80.2%
0.00%
-75.0%
Q4 2020$254,000
-46.9%
112,846
-53.3%
0.00%
-42.9%
Q3 2020$478,000
+346.7%
241,616
+372.8%
0.01%
+250.0%
Q2 2020$107,00051,0980.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders